| Name | Title | Contact Details |
|---|
HARRIS, RON is a Oklahoma City, OK-based company in the Computers and Electronics sector.
authID.ai (formerly Ipsidy, Inc.) is a leading provider of secure, mobile, biometric identity proofing and authentication solutions delivered by an easy to integrate Identity as a Service (IDaaS) platform. Our mission is to eliminate all passwords and to be the preferred global platform for biometric identity authentication. Our vision is to enable every organization to “Recognise Your Customer” instantly, without friction or loss of privacy, powered by the most sophisticated biometric and artificial intelligence technologies. authID is committed to expanding our AI capabilities, and enhance our IDaaS platform to deliver the highest levels of performance, speed, and accuracy along with reduced friction, increased security, and privacy for consumers. Our goal is to make authID the simplest and most comprehensive identity solution available, enabling our customers to effortlessly identify, activate, and authenticate new consumers globally through a single platform.
InfoStructures is a Rockville, MD-based company in the Computers and Electronics sector.
Deep Lens is extending one of the World`s first digital pathology cloud platforms that for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.
SolveBio equips you with Genomic Intelligence to guide you through a complex world towards innovation and discovery — driving precision medicine, advancing human health. Today, enterprises that endeavor to utilize genomics must navigate the ever-changing world of data, studies, and expert opinions. No matter the credibility of their sources or strength of their models, these will often conflict, simply because human biology and scientific discovery are dynamic and complex. To mainstream precision medicine, life science enterprises need to convert the complexity of biology into an easily distributed, readily deployed information asset. We call this Genomic Intelligence.